Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fletcher

Showing results (701-710 of 712) with videos related to

Pageof 72
Sort By:
Diabetes|November 28, 2007
Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulationGreg Simon, Matthew Parker, Vijayakumar Ramiya, et al.
Journal of Medicinal Chemistry|January 11, 2002
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonistsStephen R Fletcher, Frank Burkamp, Peter Blurton, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Annals of Surgery|September 25, 2012
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppressionStefan Schneeberger, Vijay S Gorantla, Gerald Brandacher, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisMark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 24, 2018
Commentaries on Viewpoint: Use aerobic energy expenditure instead of oxygen uptake to quantify exercise intensity and predict endurance performanceKyle R Barnes, Andrew E Kilding, Richard C Blagrove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) StudyElise A Mitri, Sara Vogrin, Camille Paynter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) StudyElise A Mitri, Luke R Fletcher, Sara Vogrin, et al.
Genome Research|July 3, 2014
Comparative validation of the D. melanogaster modENCODE transcriptome annotationZhen-Xia Chen, David Sturgill, Jiaxin Qu, et al.
Journal of Tissue Viability|May 13, 2025
Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intentionRhiannon Macefield, Laura Mandefield, Jane M Blazeby, et al.
Pageof 72

Showing results (701-710 of 712) with videos related to

Sort By:
Pageof 72
Diabetes|November 28, 2007
Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulationGreg Simon, Matthew Parker, Vijayakumar Ramiya, et al.
Journal of Medicinal Chemistry|January 11, 2002
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonistsStephen R Fletcher, Frank Burkamp, Peter Blurton, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Annals of Surgery|September 25, 2012
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppressionStefan Schneeberger, Vijay S Gorantla, Gerald Brandacher, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisMark E Schnute, Patrick M O'Brien, Joe Nahra, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 24, 2018
Commentaries on Viewpoint: Use aerobic energy expenditure instead of oxygen uptake to quantify exercise intensity and predict endurance performanceKyle R Barnes, Andrew E Kilding, Richard C Blagrove, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
Direct Oral Challenge for Penicillin Allergy: A Hospital Implementation Evaluation Via the International Network of Antibiotic Allergy Nations (iNAAN) StudyElise A Mitri, Sara Vogrin, Camille Paynter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
Direct Oral Challenge for Penicillin Allergy: The International Network of Antibiotic Allergy Nations (iNAAN) StudyElise A Mitri, Luke R Fletcher, Sara Vogrin, et al.
Genome Research|July 3, 2014
Comparative validation of the D. melanogaster modENCODE transcriptome annotationZhen-Xia Chen, David Sturgill, Jiaxin Qu, et al.
Journal of Tissue Viability|May 13, 2025
Modification and validation of the Bluebelle Wound Healing Questionnaire (WHQ) for assessing surgical site infection in wounds healing by secondary intentionRhiannon Macefield, Laura Mandefield, Jane M Blazeby, et al.
Pageof 72